Cancer Drug Could Help Women Tackle Midlife Weight Gain, Study Finds
Summary
A drug originally made to fight cancer called CADD522 helped strengthen bones and reduce body fat in older female mice that no longer produce estrogen. The study suggests this drug might help women during menopause manage weight gain and bone loss, but the drug is still being tested and has only been used in animals so far.Key Facts
- CADD522 was created to block a protein that helps cancer tumors grow.
- In mice without estrogen (similar to postmenopausal women), CADD522 made bones stronger and improved bone structure.
- Mice given CADD522 weighed less and had less body fat despite eating the same amount as untreated mice.
- The drug also reduced fat buildup inside bone marrow, which often happens after menopause and harms bones.
- Researchers saw healthier fat metabolism in the brain of treated mice, which might relate to better brain health.
- CADD522 was safe in tests on mice, rats, and dogs and can be taken by mouth.
- The drug breaks down slower in human tissue, which could make it more effective in people.
- More studies are needed to test if CADD522 works and is safe for women, especially those with bone loss or near menopause.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
